<DOC>
	<DOC>NCT00441012</DOC>
	<brief_summary>To determine if there is an improvement in the immune response to HBsAg (hepatitis B virus) in healthy infants using a modified process in a combination Haemophilus Influenzae, type b/Hepatitis B vaccine and a currently licensed Haemophilus Influenzae, type b/Hepatitis B vaccine</brief_summary>
	<brief_title>Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy 2monthold full term infants born to nonHBs Ag (hepatitis B virus) carrier mothers Birth mother known to be a carrier of hepatitis B virus (HBsAg+) or known carriers ever living in close contact with the subject History of previous hepatitis B infection; history of vaccination with any hepatitis B vaccine Recent (&lt;72 hours) history of febrile illness (rectal temperature &gt;=38.1°C/&gt;=100.5°F) Known or suspected hypersensitivity to any component of RECOMBIVAXHB™ or COMVAX™ (e.g., aluminum, yeast) Recent administration (w/i 3 months prior to study start) of hepatitis B immune globulin (HBIg), serum immune globulin, or any other bloodderived product Receipt of investigational drugs or investigational vaccines within 3 months prior to study start or if planned within the study period; Known or suspected impairment of immunologic function or recent use (within 3 months prior to study start) of immunomodulatory medications (does not include topical and inhaled steroids); Any condition that, in the opinion of the investigator, might interfere with the evaluation of study objectives; or inability to comply with the study schedule and/or inability to attend all required study visits</criteria>
	<gender>All</gender>
	<minimum_age>40 Days</minimum_age>
	<maximum_age>80 Days</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Haemophilus Influenza, type b and Hepatitis B</keyword>
</DOC>